Separate terms with OR to return results that match either term.
 
Clear All

10,000 Matching ResultsExport these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) (Descending) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
55513-0032-01 55513-0032 Darbepoetin alfa Aranesp 500.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous June 7, 2006 In Use
55513-0028-01 55513-0028 Darbepoetin alfa Aranesp 200.0 ug/.4mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 14, 2006 In Use
55513-0027-04 55513-0027 Darbepoetin alfa Aranesp 150.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0027-01 55513-0027 Darbepoetin alfa Aranesp 150.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Feb. 18, 2011 In Use
55513-0025-04 55513-0025 Darbepoetin alfa Aranesp 100.0 ug/.5mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 14, 2006 In Use
55513-0025-01 55513-0025 Darbepoetin alfa Aranesp 100.0 ug/.5mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Feb. 18, 2011 In Use
55513-0023-04 55513-0023 Darbepoetin alfa Aranesp 60.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 14, 2006 In Use
55513-0023-01 55513-0023 Darbepoetin alfa Aranesp 60.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Feb. 18, 2011 In Use
55513-0021-04 55513-0021 Darbepoetin alfa Aranesp 40.0 ug/.4mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Aug. 14, 2006 In Use
55513-0021-01 55513-0021 Darbepoetin alfa Aranesp 40.0 ug/.4mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Feb. 18, 2011 In Use
55513-0015-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Aug. 19, 2002 April 30, 2009 No Longer Used
55513-0014-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Feb. 28, 2009 No Longer Used
55513-0013-04 55513-0013 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 April 30, 2009 No Longer Used
55513-0013-01 55513-0013 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 April 30, 2009 No Longer Used
55513-0012-04 55513-0012 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Dec. 31, 2008 No Longer Used
55513-0012-01 55513-0012 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Dec. 31, 2008 No Longer Used
55513-0011-04 55513-0011 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Nov. 30, 2008 No Longer Used
55513-0011-01 55513-0011 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Nov. 30, 2008 No Longer Used
55513-0010-04 55513-0010 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 March 31, 2009 No Longer Used
55513-0010-01 55513-0010 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 March 31, 2009 No Longer Used
55513-0006-01 55513-0006 Darbepoetin alfa Aranesp 200.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0005-04 55513-0005 Darbepoetin alfa Aranesp 100.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0005-01 55513-0005 Darbepoetin alfa Aranesp 100.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0004-04 55513-0004 Darbepoetin alfa Aranesp 60.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0004-01 55513-0004 Darbepoetin alfa Aranesp 60.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0003-04 55513-0003 Darbepoetin alfa Aranesp 40.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0003-01 55513-0003 Darbepoetin alfa Aranesp 40.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0002-04 55513-0002 Darbepoetin alfa Aranesp 25.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0002-01 55513-0002 Darbepoetin alfa Aranesp 25.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55390-0826-01 55390-0826 Leucovorin Calcium Leucovorin Calcium Ancillary Therapy Chemoprotective Antidote Sept. 28, 2001 June 30, 2013 No Longer Used
55390-0825-01 55390-0825 Leucovorin Calcium Leucovorin Calcium Ancillary Therapy Chemoprotective Antidote Sept. 28, 2001 May 31, 2013 No Longer Used
55390-0824-01 55390-0824 Leucovorin Calcium Leucovorin Calcium Ancillary Therapy Chemoprotective Antidote June 28, 1996 April 30, 2014 No Longer Used
55390-0818-10 55390-0818 Leucovorin Calcium Leucovorin Calcium Ancillary Therapy Chemoprotective Antidote June 28, 1996 Aug. 31, 2014 No Longer Used
55390-0809-01 55390-0809 Cytarabine Cytarabine Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, subcutaneous, intrathecal June 28, 1996 Dec. 31, 2010 No Longer Used
55390-0808-01 55390-0808 Cytarabine Cytarabine Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, subcutaneous, intrathecal June 28, 1996 Aug. 31, 2014 No Longer Used
55390-0807-10 55390-0807 Cytarabine Cytarabine Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, subcutaneous, intrathecal June 28, 1996 March 31, 2013 No Longer Used
55390-0806-10 55390-0806 Cytarabine Cytarabine Chemotherapy Antimetabolite Pyrimidine Analog Intravenous, subcutaneous, intrathecal June 28, 1996 July 31, 2013 No Longer Used
55390-0805-10 55390-0805 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 28, 1996 April 30, 2013 No Longer Used
55390-0493-01 55390-0493 Etoposide Etoposide Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Sept. 28, 2001 May 31, 2013 No Longer Used
55390-0492-01 55390-0492 Etoposide Etoposide Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Oct. 22, 2001 Jan. 31, 2013 No Longer Used
55390-0491-01 55390-0491 Etoposide Etoposide Chemotherapy Plant Alkaloid Epipodophyllotoxins Intravenous Oct. 22, 2001 March 31, 2012 No Longer Used
55390-0453-01 55390-0453 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Oct. 11, 2001 Oct. 31, 2012 No Longer Used
55390-0452-01 55390-0452 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Sept. 28, 2001 Jan. 31, 2013 No Longer Used
55390-0451-01 55390-0451 Mitomycin Mitomycin Chemotherapy Antitumor Antibiotic Alkylating Agent/ Mitomycin Intravenous Sept. 28, 2001 Nov. 30, 2012 No Longer Used
55390-0391-50 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
55390-0391-10 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
55390-0377-01 55390-0377 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 April 30, 2013 No Longer Used
55390-0376-10 55390-0376 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 Jan. 31, 2013 No Longer Used
55390-0375-10 55390-0375 Octreotide Acetate Octreotide Acetate Hormonal Therapy Somatostatin Analog March 9, 2009 April 30, 2013 No Longer Used
55390-0370-10 55390-0370 Topotecan Hydrochloride Topotecan Hydrochloride 4.0 mg/4mL Chemotherapy Topoisomerase I Inhibitor Camptothecin Analogs Intravenous Dec. 1, 2020 In Use

Found 10,000 results in 11 millisecondsExport these results